L-glutamic acid derivatives
US4871743A · kind A · utility
21Cited by
1References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 19, 1988 |
| Grant date | Oct 3, 1989 |
| Priority date | — |
| Expiry date | Jan 19, 2008 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/545
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Pyrimidin-5-yl derivatives of L-glutamic acid are anti-neoplastic agents. A typical embodiment is N-(4-[4-(2,4-diamino-6-hydroxypyrimidin-5-yl)-butyl]-benzoyl)-L-glutamic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.